The RE-UNITE-PN Study Design – A Prospective, Non-Interventional, Phase 4 Study of Nemolizumab for the Treatment of Prurigo Nodularis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 10, n. 2, p. s767, 2026. DOI: 10.25251/q0ctfz86. Disponível em: https://skin.dermsquared.com/skin/article/view/4122. Acesso em: 1 may. 2026.